Researchers at Canada’s University of British Columbia (UBC) determined that despite a decline in smoking rates, there will be an epidemic of chronic obstructive pulmonary disease (COPD) over the next two decades, with the potential to overwhelm healthcare systems. The report with the predictions was published in the American Journal of…
The benefits of physical activity are widely accepted by scientists and doctors today, with effects observed in weight control, as well as mood and mental health. Now research is showing that increased physical activity among patients with chronic obstructive pulmonary disease (COPD) reduces their risk of anxiety and depression. Results from…
Positive results from a real-world study were recently presented evaluating the effectiveness of the Aerobika Oscillating PEP nondrug device in reducing chronic obstructive pulmonary disease (COPD) exacerbations. Trudell Medical International presented the results of the study at the European Respiratory Society (ERS) International Congress Sept. 3-7 in London. Trudell…
GlaxoSmithKline (GSK) recently presented data showing that its combination drug Relvar Ellipta (fluticasone furoate and vilanterol) causes a statistically significant reduction in the rate of severe lung exacerbations in patients in the Salford Lung Study (SLS), which assessed the safety and effectiveness of the drug in patients with chronic obstructive pulmonary disease (COPD).
Royal Philips is sponsoring the documentary “COPD: Highly Illogical – Remembering Leonard Nimoy,” a tribute that aims to educate viewers about chronic obstructive pulmonary disease (COPD) through the personal journey of the “Star Trek” star while also providing the latest information about available treatments. The documentary is produced by Nimoy’s daughter, Julie Nimoy, and…
Boehringer Ingelheim recently held  a 2nd respiratory forum that focused on the growing problem of lung disease across the Middle East and North Africa, and served as a platform for specialists from those regions and Europe to discuss the clinical management and diagnosis of these diseases, and future challenges in controlling their prevalence. The theme for…
PN Medical and Orbita announced they have formed a partnership to leverage Orbita’s next-generation digital platform with its own products, designed to enable clinicians to better monitor and support patients with chronic conditions like chronic obstructive pulmonary disease (COPD), hypertension, and congestive heart failure. “In 1980, we were first to…
DS Biopharma of Dublin, Ireland, announced the launch of a spinoff company, Afimmune, to focus on pulmonary disorders like COPD and fibrotic conditions such as NASH. Fibrosis means the development of fibrous connective scar tissue created in response to injury or damage. Fibrotic diseases are conditions in which fibrosis occurs,…
Patients with chronic obstructive pulmonary disease (COPD) who exhibit asthma symptoms may have poorer outcomes than other COPD patients, according to a study developed by researchers at St Paul’s Hospital in Vancouver, British Columbia. The study, “Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap…
AstraZeneca recently announced positive top-line data from two international, multi-center clinical trials in adult patients with chronic obstructive pulmonary disease (COPD) and in pediatric patients with asthma. The results show that Symbicort inhalation aerosol was well tolerated and achieved primary endpoints in both studies. Symbicort is a combination of budesonide,…
Get regular updates to your inbox.